Pfizer, Inc.

PFE

US7170811035

Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (52.3%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (25.6%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (19.9%); - other (2.2%). Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (33.8%).

Employees

88,000

Sector

Pharmaceuticals

Calendar

03/02/2025 - Q4 2024 Earnings Release (Projected)

More about the company

Income Statement and Estimates

income-statement-evolution-chart PFIZER-INC

More financial data

Analysis / Opinion

Pfizer, Inc. under full-scale attack

October 08, 2024 at 11:17 am

Starboard Takes $1B Stake in Pfizer

October 07, 2024 at 08:45 pm

More Strategies

Ratings

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

25.82USD

Average target price

32.66USD

Spread / Average Target

+26.49%

Consensus

Profit revisions

Estimate revisions

Quarterly revenue - Rate of surprise

Company calendar

Market Closed - Nyse Other stock markets 21:00:14 02/12/2024 GMT			5-day change	1st Jan Change
25.82 ^USD	-1.49%		-1.34%	-10.32%

11-29	Analyst recommendations: Apple, Dell, Pfizer, Wall Disney, GSK...
11-25	Health Care Up Amid Cyclical Bias -- Health Care Roundup	DJ

Analyst recommendations: Apple, Dell, Pfizer, Wall Disney, GSK...	11-29
Health Care Up Amid Cyclical Bias -- Health Care Roundup	11-25	DJ
GC Biopharma USA Names Sean Zam as Head of Sales and Marketing	11-22	CI
Sector Update: Health Care Stocks Rise Pre-Bell Thursday	11-21	MT
Zai Lab, Pfizer Collaborate for Marketing Antibacterial Drug in China	11-21	MT
Zai Lab and Pfizer Announce Strategic Collaboration on the Novel Antibacterial Drug Xacduro® (Sulbactam-Durlobactam)	11-21	CI
UK Tribunal Fines Pfizer, Flynn GBP69 Million For Excessive Pricing of Epilepsy Medicine	11-21	MT
Health Care Climbs as Obesity-Drug Makers Rebound - Health Care Roundup	11-20	DJ
US CDC expects COVID and RSV levels to increase in coming weeks	11-20	RE
Pfizer, Flynn Get Fined $87.3 Million by UK Tribunal for Excessive Pricing on Epilepsy Drug	11-20	MT
UK Tribunal Fines Pfizer, Flynn $87.3 Million for Excessive Pricing	11-20	MT
European Equities Close Lower in Wednesday Trading; ECB Sees Elevated Financial Stability Risk	11-20	MT
Top Midday Stories: Comcast to Spin Off Cable TV Networks; Target Tumbles on Q3 Earnings Miss, Lowered Full-Year Guidance	11-20	MT
Global markets live: Pfizer, Alphabet, Comcast, Ford, Nokia...	11-20
Nvidia's market might	11-20
Pfizer's Hympavzi Gets EU Marketing Authorization for Severe Hemophilia A, B	11-20	MT
Pfizer: Marketing authorization for Hympavzi in the EU	11-20	CF
Pfizer: new Chief Scientific Officer on January 1	11-20	CF
Pfizer Names Chris Boshoff as Chief Scientific Officer, R&D Head	11-20	MT
Pfizer Names Chris Boshoff Chief Scientific Officer, President of Research & Development, Effective Jan. 1	11-20	MT
Pfizer Says European Commission Approves Hemophilia Treatment	11-20	MT

Pfizer, Inc.

Equities

PFE